Present and future strategies of treatment in childhood Hodgkin's lymphomas

Annals of Oncology

Volumn 7, Issue SUPPL. 4, 1996, Pages

  Oberlin, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Childhood; Hodgkin's disease; Treatment

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOGUAZONE; NAVELBINE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HODGKIN DISEASE; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION FIELD;

EID: 0029797968     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_4.S73     Document Type: Conference Paper

References (29)

1. Jenkin RD, Berry MR Hodgkin's disease in children. Semin Oncol 1980;7:202-11.
2. DeVita VT, Serpick A, Carbone PP. Combination chemotherapy in the treatment of advanced HD. Ann Intern Med 1970; 73:881-95.
3. Willman JY, Cox RS, Donaldson SS. Radiation induced height impairement in pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys 1994;28:85-92.
4. Hancock SL, Tucker MA, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993;11:1208-15.
5. Bhatia S, Robinson L, Oberlin O et al. Second malignant neoplasms following Childhood Hodgkin's disease: Follow-up of the Late Effect Study Group cohort. Proc Am Soc Clin Oncol 1995;14:409 (Abstr. 1293).
6. Specht L, Carde P, Mauch P et al. Radiotherapy versus combined modality in early stages. Ann Oncol 1991; 2 (Suppl 4): 77-81.
7. Olweny CL, Katongole-Mbidde E, Kllre C et al. Childhood Hodgkin's disease in Uganda. Cancer 1971;27:1295-301.
8. Ekert H, Waters KD, Smith PJ et al. Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. J Clin Oncol 1988;6:1845-50.
9. Martin J, Radford M. Current practice in Hodgkin's disease. The United Kingdom Children's Cancer Study Group. In Kamps WA, Humphrey GB, Poppema S (eds): Hodgkin's disease in Children: Controversies and Current Practice. Boston: Kluwer Academic Publishers 1989;263-75.
10. Behrendt H, Van Bunningen B, Van Leeuwen EF, Treatment of HD in children without radiotherapy. Cancer 1987; 59: 1870-3.
11. Weiner M, Leventhal B, Brecher M et al. A randomized study of intensive MOPP-ABVD + low dose totam nodal irradiation therapy in the treatment of stages IIB, IIIA2, IIIB, IV Hodgkin's disease: A Pediatric Oncology Group Study. Proc Am Soc Clin Oncol 1995;14:408 (Abstr. 1292).
12. Fryer CJ, Hutchinson RJ, Krailo M et al. Efficacy and toxicity of 12 courses of ABVD chemotherapy followed by low-dose regional radiation in advanced Hodgkin's disease in children: A report from the Childrens Cancer Study Group. J Clin Oncol 1990;8:1971-80.
13. Gehan EA, Sullivan MP, Fuller LM et al. The Intergroup Hodgkin's disease in children. A study of stages I and II. Cancer 1990;65:1429-37.
14. Oberlin O, Biolletot A, Leverger G et al. Clinical staging, primary chemotherapy and involved field radiotherapy in childhood Hodgkin's disease. Eur Paediatr Hematol Oncol 1985;2:65-70.
15. Balwierz W, Armata J, Moryl-Bujakowska A et al. Chemotherapy combined with involved field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987. Acta Paediatr Jpn 1991;33:703-8.
16. Donaldson SS, Link MP. Combined modality treatment with low-dose radiation for children with Hodgkin's disease. J Clin Oncol 1987;5:742-9.
17. Jenkin RD, Chan H, Freeman M et al. Hodgkin's disease in children: Treatment results with MOPP and low-dose, extended field irradiation. Cancer Treat Rep 1982;66:949-59.
18. Oberlin O, Leverger G, Paquement H et al. Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease. The experience of the French Society of Pediatric Oncology. J Clin Oncol 1992;10:1602-8.
19. Vecchi V, Pileri S, Burneli R et al. Treatment of pediatric Hodgkin's disease tailored to stage, mediastinal mass and age. Cancer 1994;72:2049-57.
20. Schellong G, Brämswig JH, Hörnig-Franz I. Treatment of children with Hodgkin's disease. Results of the German Pediatric Oncology Group. Ann Oncol 1992;3:73-6.
21. Fermé C, Teillet F, D'Agay MF et al. Surgical restaging after 3 or 6 courses of MOPP chemotherapy in Hodgkin's disease. In Cavalli F, Bonadonna G, Rozencweig M (eds): Malignant Lymphomas and Hodgkin's disease: Experimental and Therapeutic Advances. Boston: Martinus Nijhoff Publishing 1985: 363-70.
22. Bonadonna G, Valagussa P, Santoro A et al. Hodgkin's disease: The Milan experience with MOPP and AVBD. In Diehl V, Pfreundschuh M, Loeffler M (eds): New Aspects in the Diagnosis and Treatment of Hodgkin's Disease. Berlin: Springer-Verlag 1989:169-74.
23. Canellos PG, Anderson JR, Katheleen JP et al. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD or MOPP alternating with ABVD. N Engl J Med 1992;327:1478-84.
24. Fossati-Bellani F, Gasparini M, Ballerini E et al. ABVD and limited field radiotherapy in 85 consecutive children with stage I-III Hodgkin's disease. Med Pediatr Oncol 1993; 21: 543 (Abstr.).
25. Meffered JM, Donaldson SS, Link MP. Pediatric Hodgkin's disease: Pulmonary, cardiac and thyroid function following combined modality therapy. Int J Radiat Oncol Biol Phys 1989; 16: 679-85.
26. Schellong G, Brämswig JH, Hörnig-Franz I et al. Hodgkin's disease in children: Combined modality treatment for stages IA, IB and IIA. Results in 356 patients of the German/ Austrian Pediatric Study Group. Ann Oncol 1994; 5 (Suppl 2): 113-5.
27. Schellong G, Hörnig-Franz I, Rath B. OEPA versus OPPA in combined modality treatment of Hodgkin's disease. Preliminary results of the German-Austrian multicentric trial DAL HD 90. Med Pediatr Oncol 1994;23:0-61 (Abstr.).
28. Hudson MM, Weinstein HJ, Donaldson SS et al. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol 1993;11:1080-4.
29. Landman-Parker J, Oberlin O, Pacquement H et al. Localized Hodgkin's disease: Chemotherapy regimen with VP16, Bleomycine, Vinblastine and Prednisone before low-dose radiation therapy. Results of the study by the French Society of Pediatric Oncology. Third International Symposium on Hodgkin's Lymphoma. Köln 1995:188 (Abstr.).